The Secretariat is happy to consider articles for publication on this website about anti-leprosy activities, including disability and development-related issues.
If you have some news, a story to share or an idea for an article, please contact ILEP by writing to: ilep@ilep.org.uk
Discover the real stories...
Novartis to Continue Free Provision of MDT to End of 2015
Posted on 12 October 2010 by
At a ceremony on 11th October 2010 at the headquarters of the World Health Organization in Geneva, Novartis committed to supplying multidrug therapy (MDT) free of charge to all persons affected by leprosy for another five years.
Dr Margaret Chan, Director-General of the World Health Organization, Joseph Jimenez, the Chief Executive of Novartis and Klaus Leisinger of the Novartis Foundation for Sustainable Development signed a Memorandum of Understanding that Novartis will continue to provide free MDT to every country around the world. This new Memorandum of Understanding will come into effect from January 2011 and be valid through to December 2015, the period of the new Enhanced Global Strategy for Further Reducing the Disease Burden Due to Leprosy (Plan Period 2011 – 2015). Novartis has been donating MDT in this way since the year 2000.
See Novartis press release:
Categories: News and Notes